Dinesh Selva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dinesh Selva has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Celia Chen
2 shared publications- Shyamala C. Huilgol
Department of Dermatology, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, 5000, Australia
2 shared publications Caroline Laforest
Oculoplastic & Orbital Unit, Department of Ophthalmology, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia
1 shared publicationCelia S Chen
Royal Adelaide Hospital, Adelaide, SA
1 shared publicationCraig James
Adelaide Pathology Partners, Adelaide, SA
1 shared publicationGarry J. Davis
1 shared publication
Latest Publications
- 1 January 2005
- Published by Springer Nature in Drugs
- Vol. 65 (13) , 1767-1779
Autoimmune Bullous Diseases
The ocular manifestations of autoimmune bullous diseases are common and potentially sight-threatening. Major ophthalmic involvement is most commonly seen in mucous membrane pemphigoid (cicatricial pemphigoid), epidermolysis bullosa acquisita, linear IgA bullous disease, pemphigus vulgaris and paraneo-plastic pemphigus. The main pathological process is related to autoimmune-induced onjunctival inflammation with consequent lid and corneal pathology, which may eventually result in permanent visual loss. Ocular involvement can be asymptomatic. Early detection is aided by careful attention to symptoms and signs of early ophthalmic disease. Ocular disease can be difficult to treat and management usually involves systemic therapy with immunomodulators to control inflammation and prevent progression to irreversible blindness, as well as surgical intervention in advanced disease. Recent advances in treatment, including methotrexate, mycophenolate mofetil, monoclonal antibodies and topical tacrolimus therapies, have led to promising results.
- 1 January 2005
- Published by Springer Nature in Drugs
- Vol. 65 (13) , 1767-1779
Autoimmune Bullous Diseases
The ocular manifestations of autoimmune bullous diseases are common and potentially sight-threatening. Major ophthalmic involvement is most commonly seen in mucous membrane pemphigoid (cicatricial pemphigoid), epidermolysis bullosa acquisita, linear IgA bullous disease, pemphigus vulgaris and paraneo-plastic pemphigus. The main pathological process is related to autoimmune-induced onjunctival inflammation with consequent lid and corneal pathology, which may eventually result in permanent visual loss. Ocular involvement can be asymptomatic. Early detection is aided by careful attention to symptoms and signs of early ophthalmic disease. Ocular disease can be difficult to treat and management usually involves systemic therapy with immunomodulators to control inflammation and prevent progression to irreversible blindness, as well as surgical intervention in advanced disease. Recent advances in treatment, including methotrexate, mycophenolate mofetil, monoclonal antibodies and topical tacrolimus therapies, have led to promising results.
- 1 June 2004
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 122 (6) , 915-917
Polymorphous Low-Grade Adenocarcinoma of the Lacrimal Gland
Case Report from JAMA Ophthalmology — Polymorphous Low-Grade Adenocarcinoma of the Lacrimal Gland
- 1 June 2004
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 122 (6) , 915-917
Polymorphous Low-Grade Adenocarcinoma of the Lacrimal Gland
Case Report from JAMA Ophthalmology — Polymorphous Low-Grade Adenocarcinoma of the Lacrimal Gland
- 4 February 2004
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 32 (1) , 46-50
Late reactivation of thyroid orbitopathy
Background: Thyroid orbitopathy is characterized by spontaneous remissions and exacerbations. Although data on the natural history are scarce, the active phase is usually self‐limited, encompassing an average period of 18−36 months. Late reactivation, defined as active orbitopathy occurring after more than 5 years of quiescent disease, appears to be an uncommon and poorly documented event. The aim of the present study was to assess the incidence and characteristics of late reactivation of thyroid orbitopathy within a tertiary referral orbital clinic. Methods: A retrospective case review was conducted of patients with thyroid orbitopathy seen at the Royal Adelaide Hospital Orbital Clinic between 1996 and 2001. Results: From 193 cases of thyroid orbitopathy, eight cases (5%) of late reactivation were identified. The mean age of patients was 51 years (range 32−76 years) with a female to male ratio of 3:1. All cases presented with proptosis and seven demonstrated increased diplopia and gaze restriction. Signs of soft tissue inflammation were seen in three cases. All were euthyroid at presentation with a past history of thyroid orbitopathy and hyperthyroidism. One patient had an association of smoking with reactivation but the remainder had no discernible precipitants. The average interval between the initial orbitopathy and reactivation was 12 years (range 6−30 years). Computed tomography revealed enlarged extraocular muscles in seven cases and two showed partial response to treatment with low dose radiotherapy and steroids. The average length of disease activity was 14 months (range 9−18 months). Conclusion: Late reactivation of thyroid orbitopathy appears to be an uncommon phenomenon. It may occur under euthyroid conditions with no obvious precipitants and often presents as a reactivation of myopathy.
- 4 February 2004
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 32 (1) , 46-50
Late reactivation of thyroid orbitopathy
Background: Thyroid orbitopathy is characterized by spontaneous remissions and exacerbations. Although data on the natural history are scarce, the active phase is usually self‐limited, encompassing an average period of 18−36 months. Late reactivation, defined as active orbitopathy occurring after more than 5 years of quiescent disease, appears to be an uncommon and poorly documented event. The aim of the present study was to assess the incidence and characteristics of late reactivation of thyroid orbitopathy within a tertiary referral orbital clinic. Methods: A retrospective case review was conducted of patients with thyroid orbitopathy seen at the Royal Adelaide Hospital Orbital Clinic between 1996 and 2001. Results: From 193 cases of thyroid orbitopathy, eight cases (5%) of late reactivation were identified. The mean age of patients was 51 years (range 32−76 years) with a female to male ratio of 3:1. All cases presented with proptosis and seven demonstrated increased diplopia and gaze restriction. Signs of soft tissue inflammation were seen in three cases. All were euthyroid at presentation with a past history of thyroid orbitopathy and hyperthyroidism. One patient had an association of smoking with reactivation but the remainder had no discernible precipitants. The average interval between the initial orbitopathy and reactivation was 12 years (range 6−30 years). Computed tomography revealed enlarged extraocular muscles in seven cases and two showed partial response to treatment with low dose radiotherapy and steroids. The average length of disease activity was 14 months (range 9−18 months). Conclusion: Late reactivation of thyroid orbitopathy appears to be an uncommon phenomenon. It may occur under euthyroid conditions with no obvious precipitants and often presents as a reactivation of myopathy.
- 1 January 2004
- Published by Swets & Zeitlinger Publishers in Orbit
- Vol. 23 (1) , 49-52
Endoscopic approach to orbitofrontal cholesterol granuloma
A 54-year-old man presented with an orbitofrontal cholesterol granuloma arising in the left frontal bone and abutting the dura. The lesion was successfully removed with an anterior orbitotomy via a superior lid crease incision. A 70-degree rigid endoscope was used to visualize removal of the granuloma from the inner surface of frontal bone and the dura. The patient made an uncomplicated recovery and there was no recurrence at two years follow-up. A combined anterior orbital and endoscopic approach may be an alternative to either frontal craniotomy or lateral orbitotomy in selected cases of orbitofrontal cholesterol granuloma.
- 1 January 2004
- Published by Swets & Zeitlinger Publishers in Orbit
- Vol. 23 (1) , 49-52
Endoscopic approach to orbitofrontal cholesterol granuloma
A 54-year-old man presented with an orbitofrontal cholesterol granuloma arising in the left frontal bone and abutting the dura. The lesion was successfully removed with an anterior orbitotomy via a superior lid crease incision. A 70-degree rigid endoscope was used to visualize removal of the granuloma from the inner surface of frontal bone and the dura. The patient made an uncomplicated recovery and there was no recurrence at two years follow-up. A combined anterior orbital and endoscopic approach may be an alternative to either frontal craniotomy or lateral orbitotomy in selected cases of orbitofrontal cholesterol granuloma.
- 1 November 2003
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 117 (11) , 892-894
Orbitofrontal cholesterol granuloma: percutaneous endoscopic-assisted curettage
This paper describes the use of endoscopic visualization in curettage of orbital cholesterol granuloma (OCG). Two males aged 54 and 50 years presented with orbitofrontal cholesterol granulomas arising in the superolateral frontal bone and abutting the dura. The granulomas were approached via a superior eyelid crease incision and a 70 degree rigid endoscope was used to visualize curettage of the granuloma from the inner surface of the frontal bone and the dura. Both patients made an uncomplicated recovery and there was no recurrence at eight months and two years follow up.Percutaneous endoscopic curettage is an alternative to blind curettage, lateral orbitotomy or frontal craniotomy for OCG.
- 1 November 2003
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 117 (11) , 892-894
Orbitofrontal cholesterol granuloma: percutaneous endoscopic-assisted curettage
This paper describes the use of endoscopic visualization in curettage of orbital cholesterol granuloma (OCG). Two males aged 54 and 50 years presented with orbitofrontal cholesterol granulomas arising in the superolateral frontal bone and abutting the dura. The granulomas were approached via a superior eyelid crease incision and a 70 degree rigid endoscope was used to visualize curettage of the granuloma from the inner surface of the frontal bone and the dura. Both patients made an uncomplicated recovery and there was no recurrence at eight months and two years follow up.Percutaneous endoscopic curettage is an alternative to blind curettage, lateral orbitotomy or frontal craniotomy for OCG.
- 30 April 2003
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 44 (2) , 126-128
Recurrent morphoeic basal cell carcinoma at the lateral canthus with orbitocranial invasion
Summary: We present a case of recurrent, nodulocystic and morphoeic basal cell carcinoma (BCC) at the lateral canthus, with clinically silent orbital and intracranial invasion which was treated with radiotherapy. Orbital invasion is a rare complication of periocular BCC and occurs primarily in high‐risk canthal lesions. Preoperative ophthalmological review and imaging should be considered in these cases.
- 30 April 2003
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 44 (2) , 126-128
Recurrent morphoeic basal cell carcinoma at the lateral canthus with orbitocranial invasion
Summary: We present a case of recurrent, nodulocystic and morphoeic basal cell carcinoma (BCC) at the lateral canthus, with clinically silent orbital and intracranial invasion which was treated with radiotherapy. Orbital invasion is a rare complication of periocular BCC and occurs primarily in high‐risk canthal lesions. Preoperative ophthalmological review and imaging should be considered in these cases.
- 21 April 2003
- Published by AMPCo in Medical Journal of Australia
- Vol. 178 (8) , 368
Muir–Torre syndrome and early detection of internal malignancy
Click on the article title to read more.
- 21 April 2003
- Published by AMPCo in Medical Journal of Australia
- Vol. 178 (8) , 368
Muir–Torre syndrome and early detection of internal malignancy
Click on the article title to read more.